WO1992011024A1 - Verwendung von hirudin und dessen muteinen sowie deren peg-derivaten zur kombinationsbehandlung von tumoren - Google Patents
Verwendung von hirudin und dessen muteinen sowie deren peg-derivaten zur kombinationsbehandlung von tumoren Download PDFInfo
- Publication number
- WO1992011024A1 WO1992011024A1 PCT/EP1991/002361 EP9102361W WO9211024A1 WO 1992011024 A1 WO1992011024 A1 WO 1992011024A1 EP 9102361 W EP9102361 W EP 9102361W WO 9211024 A1 WO9211024 A1 WO 9211024A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hirudin
- peg derivatives
- muteins
- tumors
- muteines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
- A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4500986A JPH06503819A (ja) | 1990-12-21 | 1991-12-10 | 腫瘍の併用療法へのヒルジン及びその突然変異タンパク質並びにそれらのpeg誘導体の使用 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEP4041185.0 | 1990-12-21 | ||
DE4041185A DE4041185A1 (de) | 1990-12-21 | 1990-12-21 | Verwendung von hirudin und dessen muteinen zur kombinationsbehandlung von tumoren |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1992011024A1 true WO1992011024A1 (de) | 1992-07-09 |
Family
ID=6421035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1991/002361 WO1992011024A1 (de) | 1990-12-21 | 1991-12-10 | Verwendung von hirudin und dessen muteinen sowie deren peg-derivaten zur kombinationsbehandlung von tumoren |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0563209A1 (de) |
JP (1) | JPH06503819A (de) |
CA (1) | CA2098707A1 (de) |
DE (1) | DE4041185A1 (de) |
WO (1) | WO1992011024A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2694196B1 (fr) * | 1992-07-30 | 1994-10-21 | Rochade | Composition médicinale utilisable comme agent antiviral. |
US7795205B2 (en) * | 2004-04-12 | 2010-09-14 | Canyon Pharmaceuticals, Inc. | Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1129148B (de) * | 1960-10-19 | 1962-05-10 | Egyt Gyogyszervegyeszeti Gyar | Verfahren zur Herstellung von Heparin-Derivaten zytostatisch wirkender Stoffe |
EP0260645A1 (de) * | 1986-09-16 | 1988-03-23 | Knoll Ag | Therapeutisches System zur lokalen Applikation von Pharmawirkstoffen |
EP0333356A2 (de) * | 1988-03-04 | 1989-09-20 | Biogen, Inc. | Hirudin-Peptide |
EP0345616A2 (de) * | 1988-06-04 | 1989-12-13 | Hoechst Aktiengesellschaft | Hirudin-Derivate mit verzögerter Wirkung |
-
1990
- 1990-12-21 DE DE4041185A patent/DE4041185A1/de not_active Withdrawn
-
1991
- 1991-12-10 JP JP4500986A patent/JPH06503819A/ja active Pending
- 1991-12-10 WO PCT/EP1991/002361 patent/WO1992011024A1/de not_active Application Discontinuation
- 1991-12-10 EP EP92901972A patent/EP0563209A1/de not_active Withdrawn
- 1991-12-10 CA CA002098707A patent/CA2098707A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1129148B (de) * | 1960-10-19 | 1962-05-10 | Egyt Gyogyszervegyeszeti Gyar | Verfahren zur Herstellung von Heparin-Derivaten zytostatisch wirkender Stoffe |
EP0260645A1 (de) * | 1986-09-16 | 1988-03-23 | Knoll Ag | Therapeutisches System zur lokalen Applikation von Pharmawirkstoffen |
EP0333356A2 (de) * | 1988-03-04 | 1989-09-20 | Biogen, Inc. | Hirudin-Peptide |
EP0345616A2 (de) * | 1988-06-04 | 1989-12-13 | Hoechst Aktiengesellschaft | Hirudin-Derivate mit verzögerter Wirkung |
Non-Patent Citations (4)
Title |
---|
FOLIA HAEMATOLOGICA, Volume 115, 1988, Leipzig, F. MARKWARDT, "the Comeback of Hirudin - an Oldestablished Anticoagulant Agent", pages 10-23. * |
HAGERS HANDBUCH DER PHARMAZEUTISCHEN PRAXIS, Volume 5, 4. Edition, 1976, SPRINGER-VERLAG, BERLIN, HEIDELBERG, NEW YORK, P.H. LIST, L. HOERHAMMER, "Hagers Handbuch der Pharmazeutischen Praxis", pages 85-87. * |
PSCHYREMBEL KLINISCHES WOERTERBUCH, C. ZINK, 255. Edition, 1986, WALTER DE GRUYTER, BERLIN, NEW YORK, pages 1775-1776. * |
ROEMPP CHEMIE LEXIKON, Volume 3, 9. Edition, 1990, GEORG THIEME VERLAG, STUTTGART, NEW YORK, J. FALBE, M. REGITZ, "Roempp Chemie Lexikon", page 1808. * |
Also Published As
Publication number | Publication date |
---|---|
EP0563209A1 (de) | 1993-10-06 |
DE4041185A1 (de) | 1992-06-25 |
CA2098707A1 (en) | 1992-06-22 |
JPH06503819A (ja) | 1994-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Takahashi et al. | Attempt at local administration of anticancer agents in the form of fat emulsion | |
EP1923073B1 (de) | Kombinationsmedikation mit PDE-5-Inhibitor | |
EP0697869A1 (de) | Transdermale therapeutische systeme zur verabreichung von serotoninagonisten | |
EP2015743B1 (de) | Glutadon | |
EP0358995A2 (de) | Verwendung von Transglutaminasen als Immunsuppressiva | |
US5116823A (en) | Drug combinations containing AZT | |
DE60116075T4 (de) | Behandlung von tumoren mit photodynamischer therapie | |
Pouillart et al. | Treatment of malignant gliomas and brain metastases in adults with a combination of adriamycin, VM 26, and CCNU. Results of a phase II trial | |
JPH0813756B2 (ja) | 細胞増殖抑制作用または細胞毒作用を有する治療用活性物質の組合せ | |
WO1992011024A1 (de) | Verwendung von hirudin und dessen muteinen sowie deren peg-derivaten zur kombinationsbehandlung von tumoren | |
DE2504331A1 (de) | Heptaminol-5'-adenosinmonophosphat und dessen therapeutische verwendung | |
DE4407484A1 (de) | Medikament zur Krebs-Therapie | |
DE4127469A1 (de) | Arzneimittel und ihre verwendung | |
DE10101522A1 (de) | Synergistische Zusammensetzung die Ascorbat und Lysin für Zustände enthält, zur Behandlung extrazellularer Matrixdegeneration | |
DE2528460A1 (de) | Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans | |
EP0433323A1 (de) | Verwendung von fibrinolytika zur kombinationsbehandlung von tumoren | |
DE602004012731T2 (de) | Zubereitungen mit verzögerter freigabe enthaltend zink, und herstellung derselben | |
Bloksma et al. | Synergistic action of human recombinant tumor necrosis factor with endotoxins or nontoxic poly A: U against solid Meth A tumors in mice | |
DE19953517C1 (de) | Verwendung von Treosulfan zur Konditionierung von Patienten vor Knochemarktransplantation oder Blutstammzelltransplantation | |
DE19721211A1 (de) | Kombination von antientzündlichen Wirkstoffen mit immunstimulierenden Agentien und zytotoxischen Agentien zur Behandlung von Tumoren | |
WO2002087304A2 (de) | Il2-peptide; von interleukin 2 abgeleitete peptide und peptid-dimere | |
JP3167763B2 (ja) | 創傷治癒促進剤 | |
DE60103016T2 (de) | Verwendung von alpha interferon zur behandlung von ewings sarcom | |
DE19732323A1 (de) | Medikamentenkombination zur erhöhten Wirkstoffkonzentration in Geweben | |
DE3603242C2 (de) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1992901972 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2098707 Country of ref document: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 1992901972 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1992901972 Country of ref document: EP |